SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israeli AI startup REplace raises $2.1M to accelerate clean energy deployment with site selection platform

Telegram's $1.745 billion bond sale severely oversubscribed

Empathy raises $72M Series C to streamline grief support and estate management

Full list of Israeli high-tech funding rounds in 2025

Buzz

Most popular

Daily

Weekly

1

Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security

2

Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal

3

Buildots raises $45M at $300M valuation to modernize global construction with AI

4

Guardicore founders raise $32 million for new stealth cyber-AI startup

5

Syte files for court protection after burning through $70 million in funding

ALS

5 stories about ALS

NeuroSense & NeuraLight R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it

מוסף שבועי 10.9.20 ד"ר פיטר סקוט־מורגן

Mind over Matter: The man who turned himself into a cyborg to overcome ALS

13.09.20|Yoghev Carmel

After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human

תרופה תרופות סל התרופות

ALS Drug Developer NeuroSense Crowdfunds $1.15 Million

05.08.19|Adi Pick

The company’s 1,114 new investors will jointly own a 10% stake, the company said

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer

The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019

חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich

Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases